Problems after corticosteroid use (muscle weakness, diabetes mellitus (DM), osteoporosis, infections, adrenal suppression, etc.), post immunosuppression effects (anti-IL-6/1), post traumatic syndrome (anxiety, panic, etc.), post thrombotic (myocardial infarction (MI), stroke), pulmonary embolism (PE), etc.), and post-ischemic (infarction, functional limitation, etc.)conditions should also be considered. This evidence concerns the gene IL6 and myocardial infarction.